| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.0074 | 0.9 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.9 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |